Ocena kliniczna skuteczności pasty do zębów Blend-a

Ocena kliniczna skuteczności pasty do zębów Blend-a

Ocena kliniczna skuteczności pasty do zębów Blend-a-med Pro-Expert Clinic Line w
znoszeniu nadwrażliwości zębiny
A clinical evaluation of the efficacy of the Blend-a-med Pro-Expert Clinic Line dentifrice
in reducing dentinal hypersensitivity
dr n. med. Małgorzata Broniarek, lek. dent. Renata Zielińska, lek. dent. Aleksandra
Szczepkowska, dr hab. n. med. Elżbieta Bołtacz-Rzepkowska, prof. nadzw.
Piśmiennictwo
References:
1. Canadian Advisory Board on Dentine Hypersensitivity: Consensus-based recommendations
for the diagnosis and management of dentin hypersensitivity. J. Can. Dent. Assoc., 2003, 69,
4: 221–228.
2. Addy M.: Dentine hypersensitivity: new perspectives on an old problem. Int. Dent. J.,
2002, 52, 5: 375–376.
3. Jacobsen P.L., Bruce G.: Clinical dentin hypersensitivity: understanding the causes and
prescribing a treatment. J. Contemp. Dental Pract., 2001, 2, 1: 1–8.
4. Orchardson R.: Clinical measurement of hypersensitive dentine. Int. Endod. J., 1993, 26: 5–
6.
5. Kaczmarek U.: Postępowanie diagnostyczno-terapeutyczne w nadwrażliwości zębiny.
Czas. Stomatol., 2006, LIX, 7: 461–472.
6. Chomyszyn-Gajewska M.: Zwiększona wrażliwość zębiny – współczesne poglądy na temat
zapobiegania i leczenia. Dent. Med. Probl., 2009, 46, 1: 110–117.
7. Rees J.S., Addy M.: A cross-sectional study of buccal cervical sensitivity in UK general
dental practice and a summary review of prevalence studies. Int. Dent. J. Hyg., 2004, 2: 64–
69.
8. Coleman T.A., Grippo J.O., Kinderknecht K.E.: Cervical dentin hypersensitivity. Part II.
Association with abfractive lesions. Quintessence Int., 2000, 31, 7: 466–473.
9. Addy M., Pearce N.: Aetiological, predisposing, and environmental factors in dentine
hypersensitivity. Arch. Oral Biol., 1994, 39, suppl.: 33S–38S.
10. Chabanski M.B. i wsp.: Clinical evaluation of cervical dentine sensitivity in a population
of patients referred to a specialist periodontology department: a pilot study. J. Oral Rehab.,
1997, 24, 9: 666–672.
11. Kumar N.G., Mehta D.S.: Short-term assessment of the Nd:YAG laser with and without
sodium fluoride varnish in the treatment of dentin hypersensitivity – a clinical and scanning
electron microscopy study. J. Periodontol., 2005, 76, 7: 1140–1147.
12. Kheirallah M., Baki H.A.: Skuteczność wybranych środków i ich wpływ na znoszenie
nadwrażliwości zębiny (szyjek zębowych). Czas. Stomatol., 1995, XLVIII, 8: 520–525.
13. Iwanicka-Frankowska E. i wsp.: Badanie porównawcze dwóch preparatów stosowanych w
nadwrażliwości zębiny. Czas. Stomatol., 1998, LI: 9–12.
14. Curro F.A.: Tooth hypersensitivity in the spectrum of pain. Dent. Clin. North Am., 1990,
34, 3: 429–437.
15. Taani S.D., Awartani F.: Clinical evaluation of cervical dentin sensitivity (CDS) in
patients attending general dental clinics (GDC) and periodontal specialty clinics (PSC). J.
Clin. Periodontol., 2002, 29, 2: 118–122.
16. Schiff T. i wsp.: Desensitizing effect of a stabilized stannous fluoride/sodium
hexametaphosphate dentifrice. Compend. Cont. Educ. Dent., 2005, 26, 9 suppl., 1: 35–40.
17. Absi E.G., Addy M., Adams D.: Dentine hypersensitivity. A study of the patency of
dentinal tubules in sensitive and non-sensitive cervical dentine. Clin. Periodontol., 1987, 14,
5: 280–284.
18. Sensabaugh S., Sagel M.E.: Stannous fluoride dentifrice with sodium hexametaphosphate:
review of laboratory, clinical and practice-based data. J. Dent. Hyg., 2009, 83, 2: 70–78.
19. Pfarrer A.M. i wsp.: Anticaries potential of a stabilized stannous fluoride/sodium
hexametaphosphate dentifrice. Compend. Cont. Educ. Dent., 2005; 26, 9 suppl., 1: 41–46.
20. Bellamy P.G. i wsp.: A randomized clinical trial to compare plaque inhibition of a sodium
fluoride/potassium nitrate dentifrice versus a stabilized stannous fluoride/sodium
hexametaphosphate dentifrice. J. Contemp. Dent. Pract., 2009, 10, 2: 1–9.
21. Schiff T. i wsp.: Anticalculus efficacy and safety of a stabilized stannous fluoride/sodium
hexametaphosphate dentifrice. Compend. Contin. Educ. Dent., 2005, 26, 9 Suppl., 1: 29–34.
22. He T. i wsp.: Extrinsic stain removal efficacy of a stannous fluoride dentifrice with
sodium hexametaphosphate. J. Clin. Dent., 2007, 18, 1: 7–11.
23. Mallatt i wsp.: A controlled 6-month clinical trial to study the effects of a stannous
fluoride dentifrice on gingivitis. J. Clin. Periodontol., 2007, 34, 9: 762–767.
24. Schiff T. i wsp.: Efficacy and safety of a novel stabilized stannous fluoride and sodium
hexametaphosphate dentifrice for dental hypersensitivity. J. Contemp. Dent. Pract., 2006, 7, 2:
1–8.
25. Chaknis P. i wsp.: Assessment of hypersensitivity reduction of a dentifrice containing
0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% NaF and specially-designed silica as
compared to a dentifrice containing 0.454% stannous fluoride, sodium hexametaphosphate
and zinc lactate and to a dentifrice containing 0.243% NaF on dentin hypersensitivity
reduction: an 8-week study. Am. J. Dent., 2011, 24, Spec. No. A: 14A–20A.
26. Radwan-Oczko M., Szulc M.: Ocena kliniczna skuteczności past Sensodyne w znoszeniu
nadwrażliwości szyjek zębów. Czas. Stomatol., 2003, LVI, 7: 454–460.
27. White D.J. i wsp.: Stannous fluoride/sodium hexametaphosphate dentifrice increases
dentin resistance to tubule exposure in vitro. J. Clin. Dent., 2007, 18, 2: 55–59.